Haichu Yu

Dr. Haichu Yu

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2025 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
MWMengmeng Wang
Mengmeng Wang
TTTianqi Teng
Tianqi Teng
NZNan Zhang
Nan Zhang
JXJiachao Xu
Jiachao Xu
ZDZihan Dong
Zihan Dong
HYHaichu Yu
Haichu Yu
The direct association between elevated levels of the triglyceride-glucose index (TyG index) and its derived metrics and the risk of new-onset hypertension in prehypertensive populations remains unclear. The study systematically evaluated the link between the TyG index and its related indicators with new-onset hypertension by integrating cohort study methods with Mendelian randomization (MR) analysis. A total of 2,815 prehypertensive participants from the 2011 CHARLS database were included, of whom 877 (31.15%) progressed to new-onset hypertension by 2015. TyG-Waist-to-Height Ratio (TyG-WHtR), TyG-Body Mass Index (TyG-BMI), TyG-Waist Circumference (TyG-WC), and the TyG index were calculated. Logistic regression, restricted cubic spline (RCS) curves, subgroup analyses, and interaction tests were performed to assess the associations. Bayesian weighted MR (BWMR) was further used to validate causal relationships. Multivariable regression analysis revealed that each unit increase in the TyG index was associated with a 45% higher risk of new-onset hypertension (odds ratio [OR]: 1.45, 95% confidence intervals [CI] 1.24–1.70, P < 0.001), while TyG-WHtR showed a 42% increased risk (OR: 1.42, 95% CI 1.26–1.60, P < 0.001). Categorizing the TyG and its derived metrics by quartiles demonstrated that higher quartiles (Q3 and Q4) were significantly linked to an elevated risk of new-onset hypertension across all models (P < 0.001). RCS models indicated significant positive linear relationships between the TyG index and TyG-WC with new-onset hypertension (P for overall < 0.001, P for nonlinearity = 0.844 and 0.165, respectively), whereas TyG-WHtR and TyG-BMI exhibited significant positive nonlinear relationships (P for overall < 0.001, P for nonlinearity = 0.001 and 0.046, respectively). Subgroup analyses highlighted stronger associations among individuals aged ≥ 70 years, those who were widowed, had cardiovascular disease, or reported a life satisfaction score of 2 (P < 0.05, P for interaction < 0.05). BWMR analysis confirmed a significant causal relationship between genetically elevated TyG index levels and an increased risk of new-onset hypertension (P < 0.05). Our study reveals a significant link between the TyG index and its related indicators with new-onset hypertension in prehypertensive populations. Causal analysis using BWMR confirmed that genetically elevated TyG index levels increase the risk of new-onset hypertension. These results highlight the importance of monitoring TyG-related indices for early detection and intervention in high-risk individuals, aiding in the prevention of hypertension progression.

12 January 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
SZShiyu Zhang
Shiyu Zhang
XLXin Liu
Xin Liu
BSBingxue Song
Bingxue Song
HYHaichu Yu
Haichu Yu
XZXiaodong Zhang
Xiaodong Zhang
YSYanming Shao
Yanming Shao
Objective The impact of serum uric acid (sUA) levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome (ACS) and hypertension after percutaneous coronary intervention (PCI) is not fully clear. This study aimed to assess the association among sUA levels, clinical prognosis and severity of coronary artery disease in patients with ACS and hypertension after PCI. Design In this prospective cohort study, we followed-up patients with ACS and hypertension after PCI for 1 year to explore the risk factors for 1 year total major adverse cardiovascular events (MACEs) and multivessel coronary artery disease, the dose-effect relationship among sUA levels, MACEs and severity of coronary artery disease and correlation between sUA levels and severity of coronary artery disease (Gensini score). Setting/patients Several Chinese internists followed-up 422 patients who were diagnosed with ACS and hypertension after PCI in a large tertiary hospital of Qingdao during the period from 1 June 2019 to 1 December 2019. Outcome measures One-year follow-up MACEs results and coronary angiography results. Results In the coronary angiography results, multivessel coronary artery disease (28.5% vs 21.4%, p=0.006) and non-culprit lesion vascular occlusion (11.7% vs 5.3%, p=0.042) were more common in the hyperuricaemia group, and the Gensini score (26.69±13.46 vs 17.66±10.57, p<0.001) was also higher. In the results of 1-year MACEs, the incidence of all-cause mortality (3.5% vs 2.5%, p=0.037), PCI or coronary artery bypass grafting therapy due to myocardial infarction or angina pectoris (15.1% vs 7.6%, p=0.027), medication conservative therapy in hospital due to myocardial infarction or angina pectoris (12.9% vs 6.7%, p=0.041) and total MACEs (31.8% vs 16.9%, p=0.001) were higher in patients with hyperuricaemia. Univariate and multivariate logistic regression analysis models showed that hyperuricaemia was still an independent risk factor for total MACEs within 1 year (OR=2.618, 95% CI 1.656 to 4.139, p<0.001; OR=1.920, 95% CI 1.158 to 3.183, p=0.011, respectively) and multivessel coronary artery disease (OR=2.140, 95% CI 1.371 to 3.342, p=0.001; OR=1.688, 95% CI 1.051 to 2.710, p=0.030, respectively) after adjusting for confounding factors. The severity of coronary artery disease (non-culprit lesion vascular occlusion (4.7% vs 8.4% vs 9.6% vs 16.2%, p=0.041); multivessel coronary artery disease (17.9% vs 22.4% vs 29.8% vs 35.2%, p=0.022); Gensini score (16.96±10.35 vs 19.31±10.63 vs 26.12±11.48 vs 33.33±14.01, p<0.001)) and the incidence of total MACEs (13.2% vs 14.2% vs 34.6% vs 41%, p<0.001) increased significantly with the sUA levels increasing. Further, the Gensini score was positively correlated with uric acid levels (r=0.515, p<0.001). Conclusions Hyperuricaemia is an independent risk factor for 1-year total MACEs and multivessel coronary artery disease in patients with ACS and hypertension after PCI.

24 July 2024 in Journal of Affective Disorders
Verified
Journal Article
Closed access
MWMengmeng Wang
Mengmeng Wang
DMDegang Mo
Degang Mo
CZChi Zhou
Chi Zhou
WZWenqiang Zhang
Wenqiang Zhang
RCRui Chen
Rui Chen
HYHaichu Yu
Haichu Yu

28 July 2024 in Heliyon
Verified
Journal Article
Open access
MWMengmeng Wang
Mengmeng Wang
DMDegang Mo
Degang Mo
NZNing Zhang
Ning Zhang
HYHaichu Yu
Haichu Yu
Diabetic cardiomyopathy (DCM) is a common complication of diabetes, and its pathogenesis remains elusive. Ferroptosis, a process dependent on iron-mediated cell death, plays a crucial role in DCM via disrupted iron metabolism, lipid peroxidation, and weakened antioxidant defenses. Hyperglycemia, oxidative stress, and inflammation may exacerbate ferroptosis in diabetes. This review emphasizes the interaction between cardiac fibroblasts and cardiomyocytes in DCM, influencing ferroptosis occurrence. By exploring ferroptosis modulation for potential therapeutic targets, this article offers a fresh perspective on DCM treatment. The study systematically covers the interplay, mechanisms, and targeted drugs linked to ferroptosis in DCM development.

21 October 2023 in Clinica Chimica Acta
Verified
Journal Article
Open access
XXXiaojian Xu
Xiaojian Xu
GZGuoliang Zhang
Guoliang Zhang
ZLZhaoqing Li
Zhaoqing Li
DLDaisong Li
Daisong Li
RCRuolan Chen
Ruolan Chen
XCXian-Ming Chu
Xian-Ming Chu
Myocardial infarction in the absence of obstructive coronary artery disease (MINOCA) is an important subtype of myocardial infarction. Although comprising less than 50% stenosis in the main epicardial coronary arteries, it constitutes a severe health risk. A variety of approaches have been recommended, but definitive diagnosis remains elusive. In addition, the lack of a comprehensive understanding of underlying pathophysiology makes clinical management difficult and unpredictable. This review highlights ongoing efforts to identify relevant biomarkers in MINOCA to improve diagnosis, individualize treatment and better predict outcomes.

5 August 2025 in BMC Medicine
Verified
Journal Article
Open access
PDF file
TTTian-Qi Teng
Tian-Qi Teng
GSGui-Xia Sun
Gui-Xia Sun
ZYZhi-Yi Yu
Zhi-Yi Yu
ZLZi-Shan Liu
Zi-Shan Liu
TWTao Wang
Tao Wang
HYHaichu Yu
Haichu Yu
Regular monitoring of blood pressure (BP) is essential for managing hypertension. The long-term effectiveness of remote monitoring in BP control requires further validation. Although self-monitoring has some benefits, its overall effectiveness remains inconclusive. In this study, we aimed to compare whether remote monitoring and self-monitoring differ from usual care in terms of their effects on BP reduction in patients with hypertension. This multicentre randomised controlled trial enrolled participants diagnosed with primary hypertension in Qingdao, China, from December 2020 to December 2021. Patients were randomly assigned to one of the following three groups: remote monitoring, self-monitoring, or usual care. All groups underwent scheduled outpatient follow-up visits every 3 months throughout the 24-month study period. The primary outcome was the adjusted mean difference in systolic BP, which was used to evaluate the effectiveness of remote monitoring and self-monitoring compared to usual care. A total of 1006 participants were analysed: 332 in the usual care group, 337 in the self-monitoring group, and 337 in the remote group. After 24 months, BP was significantly reduced in all the groups, particularly in the remote group with suboptimal baseline BP, where systolic and diastolic BP decreased by 17.7 mm Hg and 10.2 mm Hg, respectively. Compared to the usual care group, the adjusted mean difference in systolic BP for the remote group was -2.7 (-4.45, -0.96), p = 0.002, while the self-monitoring group showed no significant difference. No significant differences in diastolic BP were observed between either group and the usual care group. Attainment rates of target BP increased rapidly in the first 3 months, and continued to rise only in the remote group, reaching 69.65%. The remote group had a higher proportion of calcium channel blockers, diuretics, and combination therapy than the usual care and self-monitoring groups. Remote monitoring and guidance enhanced the efficiency of BP management, whereas self-monitoring alone proved to be ineffective. ClincialTrials.gov Identifier: NCT04690478.